SIREN : 892612359
SPFPL LAURENT PICOT PHARMACIEN is a French company founded 5 years ago, specialized in the sector Gestion de fonds. Based in TOUSSIEU (69780), this company of category PME shows in 2024 a revenue of 300€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 300 € | N/C | 3 960 € |
| Net income | -69 026 € | -14 507 € | 274 194 € |
| EBITDA | -30 827 € | -19 280 € | -4 223 € |
| Net margin | -23008.7% | N/C | 6924.1% |
In 2024, SPFPL LAURENT PICOT PHARMACIEN achieves revenue of 300 €. Revenue is declining over the period 2022-2024 (CAGR: -72.5%). After deducting consumption (0 €), gross margin stands at 300 €, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -31 k€, representing -10275.7% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -69 k€ (-23008.7% of revenue), which will impact equity.
300 €
300 €
-30 827 €
-31 736 €
-69 026 €
-1340.3%
The debt ratio (= Financial debt / Equity x 100) stands at 112%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
112.369%
47.028%
-2493.522%
-23.711
In 2024, the debt ratio of SPFPL LAURENT PICOT PHARM... (112.37) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of SPFPL LAURENT PICOT PHARM... (47.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of SPFPL LAURENT PICOT PHARM... (-23.71) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 11776.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
11776.666
-90.836
In 2024, the liquidity ratio of SPFPL LAURENT PICOT PHARM... (11776.67) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of SPFPL LAURENT PICOT PHARM... (-90.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 32 days. Excellent situation: suppliers finance 32 days of the operating cycle (retail model). WCR is negative (0 days): operations structurally generate cash.
0 €
0 j
32 j
0 j
Based on 62 transactions of similar company sales
in 2024,
the value of SPFPL LAURENT PICOT PHARMACIEN is estimated at
91 €
(range 47€ - 254€).
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SPFPL LAURENT PICOT PHARMACIEN with other companies in the same sector:
The revenue of SPFPL LAURENT PICOT PHARMACIEN in 2024 is 300€.
SPFPL LAURENT PICOT PHARMACIEN recorded a net loss in 2024.
The headquarters of SPFPL LAURENT PICOT PHARMACIEN is located in TOUSSIEU (69780), in the department Rhone.
The tax return of SPFPL LAURENT PICOT PHARMACIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SPFPL LAURENT PICOT PHARMACIEN operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.